Presentation
Session Overview
The Innovation Department is pleased to invite you to a visit from Curie.Bio on Monday, 30 March 2026.
Curie.Bio is a US-based venture capital fund with a global focus including early-stage projects. It was built to help founders discover and develop important new medicines. They do this by investing directly into existing companies, creating focused spinouts, and helping founders build companies from scratch. Curie.Bio combines two businesses in their model: they act as both a drug discovery copilot & investor. They have a 100+ person team of drug hunters, drug makers, and operators supporting founders day-to-day to increase their chances of developing medicines. Curie.Bio helps founders avoid critical mistakes and ensures they have the right plan, data, and story to maximize their value creation path. They’ve raised $1.25B and invest through two funds: the Seed Fund and the Breakout Fund. The Seed Fund focuses on advancing therapies through preclinical milestones, such as achieving in vivo proof-of-concept or selecting a development candidate. The Breakout Fund focuses on advancing medicines through clinical trials to generate impactful human activity data.
Agenda:
09:15 – 09:30: Arrival & Coffee
09:30 – 09:35: Welcome by Cristina Horcajada, Head of Innovation Department, IRB Barcelona
09:35 – 10:05: Curie.Bio’s Hands-On Approach to Investing in Therapeutic Startups
10:05 – 10:30: Q&A and Coffee Networking
Speakers:
Carlos Garcia-Echeverria, Senior Advisor - Drug Discovery & Development
Guido Boehmelt, SVP, Ambassador to Europe
Cristina Puchades, Associate, Drug Maker, Structural Biology
Registration:
Open to the PCB community (places limited). Registration required before 16 March (REGISTRATION FORM)
Date: Monday, 30 March 2026, 09:15-10:30.
Place: Dolors Aleu Room, Parc Científic de Barcelona (PCB)
Language: English
Audience: Open to the entire PCB community (places limited)
Registration: Before 16 March - LINK
